Open-label Treatment in Cushing's Syndrome

NCT03621280 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

51

Enrollment

INDUSTRY

Sponsor class

Conditions

Cushing Syndrome
Cushing Disease

Interventions

DRUG: Levoketoconazole

Sponsor

Cortendo AB